Thus, high plasma GFAP concentration was detected mainly in patients with Alzheimer’s disease dementia (Fig. 2A) while high 11C-DED binding was detected mainly in presymptomatic ADAD mutation carriers and patients with MCI+ (Fig. 2B). This evidence concerns the gene GFAP and dementia.